Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP2A6 | P11509 | 2/20 | 0.46 |
| ▸ | RAB9A | P51151 | 3/20 | 0.44 |
| ▸ | NPC1 | O15118 | 2/20 | 0.44 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.44 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.42 |
| ▸ | ACHE | P22303 | 1/20 | 0.42 |
| ▸ | NFE2L2 | Q16236 | 2/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.39 |
| ▸ | RELA | Q04206 | 1/20 | 0.38 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.38 |
| ▸ | POLB | P06746 | 1/20 | 0.38 |
| ▸ | MAPT | P10636 | 1/20 | 0.38 |
| ▸ | RECQL | P46063 | 1/20 | 0.38 |
| ▸ | MDM2 | Q00987 | 1/20 | 0.38 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.38 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.38 |
| ▸ | CA1 | P00915 | 1/20 | 0.38 |
| ▸ | FBP1 | P09467 | 1/20 | 0.35 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.35 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3225817 | 0.76 | CYP2A6 (0.44) | CYP2A6RAB9ANPC1SMN1; SMN2ALDH1A1 | |
| SCHEMBL10839051 | 0.75 | NFE2L2 (0.48) | CYP2A6RAB9ANPC1SMN1; SMN2TDP1 | |
| SCHEMBL10839054 | 0.75 | NFE2L2 (0.48) | CYP2A6RAB9ANPC1SMN1; SMN2TDP1 | |
| SCHEMBL3228392 | 0.74 | ALDH5A1 (0.46) | RAB9ANPC1SMN1; SMN2TDP1NFE2L2 | |
| SCHEMBL3227313 | 0.74 | NFE2L2 (0.42) | NFE2L2FBP1PTGS1MAOB | |
| SCHEMBL3227490 | 0.74 | HSD17B10 (0.46) | CYP2A6FBP1MAOBGRIN2DGRIN3B | |
| SCHEMBL3222382 | 0.74 | APP (0.44) | TDP1ACHEALDH1A1MAPTMAOB | |
| SCHEMBL9512577 | 0.74 | ALDH1A1 (0.46) | CYP2A6RAB9ANPC1SMN1; SMN2TDP1 | |
| SCHEMBL3223495 | 0.73 | ALDH1A1 (0.52) | CYP2A6RAB9ANPC1SMN1; SMN2NFE2L2 | |
| SCHEMBL3215228 | 0.73 | CYP1A2 (0.44) | RAB9ANPC1SMN1; SMN2TDP1ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-111116466-B | Catalytic synthesis method of polysubstituted quinoline derivative | 浙江万里学院 | 2023-02-10 | — | — | CN | claimed |
| CN-108774147-B | N-aryl formamide prepared by taking bromodifluoroacetic acid ethyl ester as formylation reagent | 温州大学 | 2021-01-08 | — | — | CN | claimed |
| CN-1934097-A | Acetylinic piperazine compounds and their use as metabotropic glutamate receptor antagonists | ASTRAZENECA AB (SE) | 2007-03-21 | — | — | CN | claimed |
| CN-115197037-A | Preparation method of acrylamide and triazole-enamide alternating copolymer | 大连理工大学 | 2022-10-18 | — | — | CN | disclosed |
| CN-108774147-B | N-aryl formamide prepared by taking bromodifluoroacetic acid ethyl ester as formylation reagent | 温州大学 | 2021-01-08 | — | — | CN | disclosed |
| US-20100069244-A1 | Pyridine Compounds for Combating Pests | BASF SE (DE) | 2010-03-18 | — | — | US | disclosed |
| CN-1934097-A | Acetylinic piperazine compounds and their use as metabotropic glutamate receptor antagonists | ASTRAZENECA AB (SE) | 2007-03-21 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100069244-A1 | Pyridine Compounds for Combating Pests | CHRM1, PRDX1, CHRM2 | CYP2A6 953/4885RAB9A 1370/4885NPC1 3639/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.